Skip to main content
. 2018 Apr 26;26(7):996–1006. doi: 10.1038/s41431-018-0096-4

Table 2.

Pathogenic or likely pathogenic variants identified in TCF4 during targeted sequencing (TES), whole exome sequencing (WES) or whole genome sequencing (WGS) in patients with intellectual disability (ID)

Cohort Reference Approach Number of patients TCF4 mutations
ID (mild to severe) this study TES (275–456 genes) 903 8
ID (mild to severe) Redin et al. [1] TES (217 genes) 106 2
ID (moderate to severe) Grozeva et al. [12] TES (575 genes) 986 2
ID Tan et al. [15] TES (90 genes) 52 2
ID (severe) Rauch et al. [14] WES 51 (1*)
ID (moderate to severe) de Ligt et al. [11] WES 100 1
ID (moderate to severe) Hamdan et al. [13] WES 41 1
Total 2239 16 (0.7%)

* de novo missense variant predicted to be benign, not included in the statistics